ANDA 77311, held by Nesher Pharms. Hydromorphone Hydrochloride.
As of Nov 16, 2026, ANDA 77311 (Hydromorphone Hydrochloride), held by Nesher Pharms, was first approved by FDA on Nov 9, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 9, 2005 | Original application | Approved | None posted |
| Hydromorphone Hydrochloride2MG · tablet;oral | Hydromorphone Hydrochloride | Discontinued |
| Hydromorphone Hydrochloride4MG · tablet;oral | Hydromorphone Hydrochloride | Discontinued |
| Hydromorphone Hydrochloride8MG · tablet;oral | Hydromorphone Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters